“…In short, according to our methods, we identified nine studies to address the presence of pancreatitis in primary hyperparathyroidism, having as a starting point a population confirmed with parathyroid NETs ( n = 7) or different types of pancreatitis ( n = 2) [ 20 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]. Seven studies were retrospective [ 20 , 27 , 28 , 29 , 30 , 32 ], one was prospective [ 26 ], and another was a registry-based cohort [ 31 ], for a total of 1375 individuals. The sample size in cohorts primarily confirmed with acute or chronic pancreatitis was 67 [ 26 ] of 100 persons [ 20 ], while within the studies firstly addressing subjects with primary hyperparathyroidism, there were 35 patients (of note, this was the single study on the pediatric population) [ 29 ], 30 persons (compared with 30 hyperparathyroidism-free controls) [ 30 ], and 51 individuals [ 27 ], for, respectively, larger cohorts of 242 [ 32 ], 386 (particularly gestational hyperparathyroidism) [ 31 ], and 464 [ 28 ] ( Table 1 ).…”